Storia in 2 fonti

Olympus to Acquire BioProtect to Expand Its Portfolio of Urological Technologies and Address Prostate Cancer

Raccontata da

morningstar.com

ynetnews.com

Confronto fonti

2 prospettive sulla stessa storia

AI · summaries

morningstar.comStai leggendo2 mesi fa

Olympus to Acquire BioProtect to Expand Its Portfolio of Urological Technologies and Address Prostate Cancer

originale

ynetnews.com2 mesi fa

Japanese medtech giant buys Israeli maker of prostate cancer protection device in $270M deal

Olympus will buy the Netanya-based maker of a biodegradable balloon implant that protects healthy tissue during prostate cancer radiation therapy, with operations expected to remain in Israel

Leggi questa versione →

Timeline cronologica

martedì 26 maggio 2026·morningstar.com
Olympus to Acquire BioProtect to Expand Its Portfolio of Urological Technologies and Address Prostate Cancer
Olympus to Acquire BioProtect to Expand Its Portfolio of Urological Technologies and Address Prostate Cancer
mercoledì 27 maggio 2026·ynetnews.com
Japanese medtech giant buys Israeli maker of prostate cancer protection device in $270M deal
Olympus will buy the Netanya-based maker of a biodegradable balloon implant that protects healthy tissue during prostate cancer radiation therapy, with operations expected to…